Immune checkpoint inhibitor–associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

A 53-year-old man with B-cell non-Hodgkin lymphoma (B-NHL) presented in October 2015 with double vision, dysarthria, ataxia and mild cognitive dysfunction since 4 weeks. From February to September, he had received nivolumab as a self-initiated maintenance therapy. He had no history of autoimmune disease.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2yokDPu
via IFTTT